BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
170 hedge funds and large institutions have $3.23B invested in Blueprint Medicines in 2017 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 72 increasing their positions, 39 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
25% more funds holding in top 10
Funds holding in top 10: 8 → 10 (+2)
23% more funds holding
Funds holding: 138 → 170 (+32)
6.93% more ownership
Funds ownership: 92.75% → 99.69% (+6.9%)
Holders
170
Holding in Top 10
10
Calls
$18.9M
Puts
$5.63M
Top Buyers
| 1 | +$104M | |
| 2 | +$58M | |
| 3 | +$54M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$42.5M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$42.4M |
Top Sellers
| 1 | -$57.5M | |
| 2 | -$55.7M | |
| 3 | -$21.9M | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
-$18.1M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$15.4M |